Table 2.
Baseline clinical variables.
| Variables | N (%) | Median (IQR) |
|---|---|---|
| Age (years), mean (SD) y | 57.9 ± 8.6 | |
| Time between initial symptoms and treatment (days) | 27 (17–47) | |
| Time between image-documented BAO and treatment (days) | 15 (IQR, 10.5–20). | |
| Pretreatment NIHSS score | 10 (4–15) | |
| Male | 19 (90.5) | |
| Hypertension | 18 (85.7) | |
| Diabetes mellitus | 5 (23.8) | |
| Hyperlipidemia | 2 (9.5) | |
| Atrial fibrillation | 0 (0) | |
| Coronary artery disease | 3 (14.3) | |
| Smoking | 9 (42.9) | |
| Technical success | 17 (81.0) | |
| 90-day mortality | 1 (4.8) | |
| Periprocedural stroke | 2 (9.5) |
BAO, basilar artery occlusion; NIHSS, National Institutes of Health Stroke Scale; IQR, interquartile range.